# FDA 483 - Naoto Ueno, M.D. - July 06, 2022

Source: https://www.keypedia.com/records/483/naoto-ueno-md/d2cdd134-5914-46eb-b64d-90e6536f6c5d

> FDA 483 for Naoto Ueno, M.D. on July 06, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Naoto Ueno, M.D.
- Inspection Date: 2022-07-06
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Naoto Ueno, M.D., a clinical investigator in Houston, TX, revealed a significant procedural issue in a clinical study. The firm failed to conduct an investigation in accordance with the signed statement of investigator and investigational plan. Specifically, concomitant medications received by subjects during the study period were not reported to the sponsor.

## Related Officers

- [CSO](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/naoto-ueno-md/db70cb42-3597-494b-be98-0dec0306e060

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab